Forbes December 10, 2024
Bruce Japsen

Walgreens Boots Alliance is considering a sale to private equity firm Sycamore Partners, according to a new report.

A three-byline “exclusive” story posted Tuesday in the Wall Street Journal comes with the drugstore giant’s stock suffering following a disastrous investment by former management in physician-staffed clinic operator VillageMD.

The newspaper said Walgreens parent and Sycamore Partners have been “discussing a deal that could be completed early next year, assuming talks don’t fall apart,” the story said, citing “people familiar with the matter.”

Such reports have emerged in the past and never turned out in the form of an actual deal or sale. There’s also been speculation in recent years that Walgreens would spin off, sell or take private its...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Trends
Mark Cuban: A Master Disrupter for American Healthcare
Despite Trump’s Tough Talk On PBMs, GOP House Lets Them Off The Hook
How has U.S. Spending on Health Care Changed Over Time?
Merck enters $2B licensing deal for weight loss drug
What are pharmacy benefit managers? A health economist explains how lack of competition drives up drug prices

Share This Article